Concepedia

Paolo Chetta

PC

8

Publications

766

Citations

8

H-Index

2018

Active since

Affiliations

Boehringer Ingelheim (Austria)(Current)

University of Milan

Dana-Farber Cancer Institute

Harvard University

Brigham and Women's Hospital

Paolo Chetta is an author at Boehringer Ingelheim (Austria) specializing in medicine, urology, and tumor biology.

ORCID

Top concepts

Publications per year

2018–2024

8

Publications

8

Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer

Giorgia Zadra, Caroline F. Ribeiro, Paolo Chetta et al. · Proceedings of the National Academy of Sciences · 2018 · 275 citations · Full text

A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo

Christiane Kofink, Nicole Trainor, Barbara Mair et al. · Nature Communications · 2022 · 194 citations · Full text

ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

Margaret M. Centenera, Julia S. Scott, Jelle Machiels et al. · Cancer Research · 2021 · 92 citations · Full text

Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging

Elizabeth C. Randall, Giorgia Zadra, Paolo Chetta et al. · Molecular Cancer Research · 2019 · 73 citations · Full text

, , +14

Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling

Birgit Wilding, Dirk Scharn, Dietrich Böse et al. · Nature Cancer · 2022 · 44 citations

, , +10

Rows per page

1–5 of 8